The DOI matches its Crossref record.
Atherosclerotic Renovascular Disease and Progressive Renal Failure
Abstract
PURPOSE: To evaluate information on the prevalence and rate of progression of atherosclerotic renovascular disease and the effect of angiotensin-converting enzyme inhibition on this process, with the goal of developing a rational approach to the diagnosis and management of this disorder. DATA SOURCES: Relevant articles were identified from the authors' files and from MEDLINE searches. Additional references were obtained from the bibliographies of identified articles. STUDY SELECTION: Virtually no controlled prospective studies have been reported. The articles presented are primarily retrospective analyses and include those that provide sufficient information about the incidence or progression of renovascular disease and about the outcome and mortality rate associated with various treatments, to allow evaluation. DATA EXTRACTION: For the outcomes of interest, data from individual reports are presented in tabular form, the results summed, and averages obtained. RESULTS: Atherosclerotic renovascular disease, in many cases involving both renal arteries, is a common finding in patients older than 50 years, particularly those with diffuse atherosclerotic vascular disease. Hypertension is not a particularly sensitive indicator of this disease (almost one half are not hypertensive). The disease progresses and may account for 5% to 15% of all patients developing end-stage renal disease each year. Angiotensin-converting enzyme inhibition may damage ischemic renal tissue, but this is counterbalanced by beneficial effects of this therapy. Once end-stage renal disease is present, mortality rates are high despite dialysis support (> 50% over 3 years). Both surgery and angioplasty can preserve or improve renal function and may delay or prevent the need for dialysis therapy. These invasive procedures may have lower rates of morbidity and mortality than the so-called "conservative" approach of dialysis therapy when renal failure develops. CONCLUSIONS: Given available information, diagnosis and intervention should be considered seriously in patients at high risk for renovascular disease who have clearly progressing renal insufficiency. Prospective trials are needed, however, to determine the costs and benefits of each approach to treatment in all patients with renovascular disease and renal insufficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
Endorsed by: the European Stroke Organisation (ESO), Authors/Task Force Members, Tendera, M., Aboyans, V., Bartelink, M.-L., Baumgartner, I., Clément, D., Collet, J.-P., Cremonesi, A., De Carlo, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr211 · Cited by 1,506
Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery Stenosis: A Randomized Trial
Plouin, P.-F., Chatellier, G., Darné, B., & Raynaud, A. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.823 · Cited by 585
Prevalence of renovascular disease in the elderly: A population-based study
Hansen, K. J., Edwards, M. S., Craven, T. E., Cherr, G. S., Jackson, S. A., Appel, R. G., Burke, G. L., & Dean, R. H. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.127351 · Cited by 506
Mailloux, L. U., Napolitano, B., Bellucci, A. G., Vernace, M., Wilkes, B. M., & Mossey, R. T. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80223-x · Cited by 374
Dorros, G., Jaff, M., Mathiak, L., Dorros, I. I., Lowe, A., Murphy, K., & He, T. (1998) · Circulation · doi:10.1161/01.cir.98.7.642 · Cited by 361
Metadata
- Authors
- Rimmer, J. M., & Gennari, F. J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1993-05-01
- Volume
- 118
- Issue
- 9
- Pages
- 712-719
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2010223481
- Cited by
- 396
- References
- 0
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atherosclerotic Renovascular Disease and Progressive Renal Failure. https://app.cochat.ai/papers/10.7326/0003-4819-118-9-199305010-00010
- The paper
- Rimmer, J. M., & Gennari, F. J. (1993). Atherosclerotic Renovascular Disease and Progressive Renal Failure. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-118-9-199305010-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.